#chronic kidney disease

This finding held true even when the researchers restricted their analysis to caffeine from soft drinks.

The single-tablet antiretroviral regimen includes Janssen’s darunavir plus Gilead’s cobicistat, emtricitabine and tenofovir alafenamide.

Researchers urge clinicians to closely monitor their patients with HIV and chronic kidney disease.

Among the hep C population, other factors associated with chronic kidney disease include being older and having diabetes or HIV.

Researchers found that those with a greater than 5 percent five-year risk of either condition also had a high risk of the other.

Merck’s hepatitis C treatment cured almost all those with stages 3 through 5 of chronic kidney disease in a VA database.

The two-drug regimen can cure the virus in as little as eight weeks.

Real-world data showed Merck’s hep C regimen performed well among a population with genotypes 1 or 4 and multiple other health conditions.

A meta-analysis of major clinical trials of hepatitis C treatments identified various subgroups who have unmet needs.

As the HIV population becomes older, an expanding proportion will need treatment for age-related conditions, which will make caring for...